BPC-157 for Injury Recovery & Tissue Repair — Performance & Recovery
Body Protective Compound-157 for accelerated healing of tendons, ligaments, muscles, and gut tissue.
Overview
BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It demonstrates remarkable tissue healing properties across multiple organ systems, particularly tendons, ligaments, muscles, and the gastrointestinal tract. Preclinical evidence shows BPC-157 promotes angiogenesis (new blood vessel formation), enhances collagen synthesis, activates growth factor pathways (VEGF, GH receptors), and reduces inflammation. While human clinical trials are limited, a 2024 systematic review of 36 studies confirms consistent injury healing benefits in animal models, and a 2020 pilot study established safety in humans. BPC-157 is especially popular among athletes and those recovering from musculoskeletal injuries or dealing with chronic gut issues.
Indications
- Tendon injuries (Achilles, rotator cuff, tennis elbow, patellar tendinitis)
- Ligament sprains and tears (ACL, MCL, ankle ligaments)
- Muscle strains, tears, and delayed healing
- Post-surgical tissue repair and recovery acceleration
- Inflammatory bowel disease (Crohn's, ulcerative colitis, leaky gut)
- GI tract protection and healing (ulcers, NSAID damage, SIBO)
- Joint pain and osteoarthritis symptom relief
- Chronic inflammation and connective tissue disorders
Mechanism of Action
Trauma to tendons, ligaments, muscles, or gastrointestinal mucosal damage triggers inflammatory cascade
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| BPC-157 | 250-500 mcg | Once daily | Most common protocol for tendon/ligament/muscle injuries. Inject near injury site if possible |
| BPC-157 | 500-750 mcg | Twice daily (morning & evening) | For acute injuries or faster healing. Split dose for sustained levels |
| BPC-157 | 500-1000 mcg | Once or twice daily on empty stomach | For IBD, leaky gut, ulcers. Take 30 min before meals for direct mucosal contact |
| BPC-157 | 250-500 mcg | Once daily | Preventive protocol for NSAID users or GLP-1 GI side effects |
| BPC-157 | 200-400 mcg | Once or twice daily | Alternative to injection, good for systemic effects and brain-gut axis support |
| BPC-157 250-500 mcg + TB-500 2-5 mg | BPC daily, TB-500 weekly | Synergistic stack for comprehensive tissue repair. TB-500 for systemic regeneration |
Evidence Grade
GRADE C
Safety & Contraindications
- Generally well-tolerated in preclinical and limited human studies
- Most common side effects: mild injection site reactions, temporary fatigue
- No serious adverse events reported in human safety trial (IV dosing up to 10 mcg/kg)
- Long-term safety data in humans is limited - use with appropriate caution
- Avoid during active cancer (promotes angiogenesis which could theoretically support tumor growth)
- Pregnancy/breastfeeding: No human data, avoid use
- May interact with anticoagulants - monitor for increased bleeding risk
- Use sterile technique for all injectable formulations
- Oral BPC-157 stability less established than injectable - refrigerate after reconstitution